Physician profile
Andre John Gauri
NPI 1215928684
$125,511.88
in general payments reported to CMS, 2019-2025
22 companies · $7,362 in 2025
The $7,362 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $32K · 2021: $23K · 2022: $35K · 2023: $11K · 2024: $5,068 · 2025: $7,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $7,934 · Travel and Lodging: $2,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,000.00 |
| Food and Beverage | $7,934.05 |
| Travel and Lodging | $2,687.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $48,012.07 | 2019-2024 | |
| Medtronic Vascular, INC. | $28,643.93 | 2019-2020 | |
| Medtronic, INC. | $24,659.66 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Na |
| Irhythm Technologies, INC. | $8,507.34 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $7,144.65 | 2019-2025 | General - Therapies, Rhythmia Mapping System, Farapulse |
| Abbott Laboratories | $4,712.44 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Biosense Webster, INC. | $2,108.23 | 2021-2025 | Carto 3, Na, Nuvision Ice Catheter |
| Medical Device Business Services, INC. | $700.00 | 2022 | |
| Acutus Medical, INC. | $200.18 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $174.84 | 2019-2022 | |
| Cardiva Medical, INC. | $135.83 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $123.71 | 2023 | Wegovy |
| Shockwave Medical, INC | $97.49 | 2022 | |
| Livanova USA, INC. | $78.79 | 2023 | Tandemheart |
| Stereotaxis INC | $57.98 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.24 | 2019-2022 | |
| Elutia, INC. | $25.12 | 2020-2024 | Ecm Patch,Pouch |
| Sk Life Science, INC. | $23.72 | 2022 | |
| Cardiovascular Systems INC. | $22.42 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.58 | 2025 | Eliquis |
| Philips North America LLC | $17.35 | 2022 | |
| Pfizer INC. | $16.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Gauri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.